divalproex sodium

Generic: divalproex sodium

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler remedyrepack inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 250 mg/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-1138
Product ID 70518-1138_485b18b2-590d-9ff6-e063-6394a90ab1c4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090161
Listing Expiration 2027-12-31
Marketing Start 2018-04-25

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705181138
Hyphenated Format 70518-1138

Supplemental Identifiers

RxCUI
1099563
UNII
644VL95AO6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA090161 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-1138-0)
source: ndc

Packages (1)

Ingredients (1)

divalproex sodium (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "485b18b2-590d-9ff6-e063-6394a90ab1c4", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099563"], "spl_set_id": ["74a9f020-f7a1-44e2-a452-f0e37bd3e077"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-1138-0)", "package_ndc": "70518-1138-0", "marketing_start_date": "20180425"}], "brand_name": "Divalproex Sodium", "product_id": "70518-1138_485b18b2-590d-9ff6-e063-6394a90ab1c4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "70518-1138", "generic_name": "Divalproex Sodium", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA090161", "marketing_category": "ANDA", "marketing_start_date": "20180425", "listing_expiration_date": "20271231"}